Physician profile
Michael D Whiting
NPI 1548220148
$802.27
in general payments reported to CMS, 2019-2025
11 companies · $105 in 2025
The $105 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.58 · 2020: $36.38 · 2021: $97.82 · 2022: $135 · 2023: $181 · 2024: $195 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $259.30 | 2022-2025 | Azstarys |
| Pfizer INC. | $176.58 | 2020-2025 | |
| Tris Pharma INC | $93.63 | 2019-2025 | Quillivant |
| Ironshore Pharmaceuticals INC. | $57.88 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $57.30 | 2022-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $52.23 | 2021-2024 | |
| Supernus Pharmaceuticals, INC. | $31.87 | 2023 | Qelbree |
| Boston Scientific Corporation | $27.83 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.11 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.69 | 2023 | |
| Seqirus USA INC | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Whiting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.